Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Elevance Health’s Executive VP Charles Kendrick sold $1.4M worth of stock, reducing his stake by 40%. While insider sales can ...

Smarter benefits equal a stronger ROI. Individualized Flexible Benefits Plans are strategic investments in workforce ...

After years of high turnover rates, Evergreen Health has reduced the outflow of employees and improved the retention rate by ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevance Health is poised for growth as industry headwinds subside. The company holds a strong market position, benefiting ...

(Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic ...

The cases, involving big companies that opted out of a big, $2.7 billion settlement, could affect employers' provider ...

Elevance Health, Inc. (ELV), with a market cap of $89.92 billion, is a leading health benefits company in the United States.

Rising Dividend Fund A Shares (without sales charge*) posted a return of -5.60% in fourth quarter 2024. Read more here.